Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Bonjournoon Aug 22, 2020 7:50am

156 Views

Post# 31441254

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Sernova still leading the pack

This is all very true, but at the end of the day a buy out is essentially the same as buying every share of the company. Hypothetically its like a big pharma company putting a bid in for 200 million shares at 5 dollars. Its a business and money is the bottom line. So why pay more for the shares at such a high multiple? We need to get the share price to a dollar before that even is even slightly reasonable. However, you are right, its not that simple. Of the demand is high enough then the supplier sets the price. Sernova is definitely building demand

Bullboard Posts

This battery metals stock is on a path to the global stage